LKB1 when associated with methylatedERα is a marker of bad prognosis in breast cancer

International Journal of Cancer

Volumn 135, Issue 6, 2014, Pages 1307-1318

  Bouchekioua Bouzaghou, Katia ^a,b,c,d   Poulard, Coralie ^a,b,c,d   Rambaud, Juliette ^a,b,c,d   Lavergne, Emilie ^e   Hussein, Nader ^f   Billaud, Marc ^g   Bachelot, Thomas ^e   Chabaud, Sylvie ^e   Mader, Sylvie ^f   Dayan, Guila ^f   Treilleux, Isabelle ^a,b,c,d,e   Corbo, Laura ^a,b,c,d   Le Romancer, Muriel ^a,b,c,d  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^d Equipe Labellisée Ligue Nationale Contre le Cancer   (France)

^e CENTRE LÉON BÉRARD   (France)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

^g INSTITUT ALBERT BONNIOT   (France)

Author keywords

biomarker; breast cancer; estrogen receptor ; estrogen signaling; LKB1

Indexed keywords

ESTROGEN RECEPTOR ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE LKB1; PROTEIN TYROSINE KINASE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CANCER SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VERY ELDERLY;

BIOMARKER; BREAST CANCER; ESTROGEN RECEPTOR Α; ESTROGEN SIGNALING; LKB1;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CELL LINE, TUMOR; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; METHYLATION; MIDDLE AGED; PHOSPHATIDYLINOSITOL 3-KINASES; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; SRC-FAMILY KINASES; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84904038159     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28781     Document Type: Article

References (35)

1. Le Romancer M, Poulard C, Cohen P, et al. Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors. Endocr Rev 2011; 32: 597-622.
2. Castoria G, Migliaccio A, Bilancio A, et al. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J 2001; 20: 6050-9.
3. Hammes SR, Levin ER,. Minireview: recent advances in extranuclear steroid receptor actions. Endocrinology 2011; 152: 4489-95.
4. Song RX, Zhang Z, Santen RJ,. Estrogen rapid action via protein complex formation involving ERalpha and Src. Trends Endocrinol Metab 2005; 16: 347-53.
5. Le Romancer M, Treilleux I, Leconte N, et al. Regulation of estrogen rapid signaling through arginine methylation by PRMT1. Mol Cell 2008; 31: 212-21.
6. Le Romancer M, Treilleux I, Bouchekioua-Bouzaghou K, et al. Methylation, a key step for nongenomic estrogen signaling in breast tumors. Steroids 2010; 75: 560-4.
7. Poulard C, Treilleux I, Lavergne E, et al. Activation of rapid oestrogen signalling in aggressive human breast cancers. EMBO Mol Med 2012; 4: 1200-13.
8. Alessi DR, Sakamoto K, Bayascas JR,. LKB1-dependent signaling pathways. Annu Rev Biochem 2006; 75: 137-63.
9. Forcet C, Billaud M,. Dialogue between LKB1 and AMPK: a hot topic at the cellular pole. Sci STKE 2007; 2007: e51.
10. Shaw RJ, Bardeesy N, Manning BD, et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 2004; 6: 91-9.
11. Jeghers H, McKusick VA, Katz KH,. Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance. N Engl J Med 1949; 241: 1031-6.
12. Hemminki A, Markie D, Tomlinson I, et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998; 391: 184-7.
13. Giardiello FM, Brensinger JD, Tersmette AC, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000; 119: 1447-53.
14. Hearle N, Schumacher V, Menko FH, et al. Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 2006; 12: 3209-15.
15. van Lier MG, Westerman AM, Wagner A, et al. High cancer risk and increased mortality in patients with Peutz-Jeghers syndrome. Gut 2011; 60: 141-7.
16. Launonen V,. Mutations in the human LKB1/STK11 gene. Hum Mutat 2005; 26: 291-7.
17. Varricchio L, Migliaccio A, Castoria G, et al. Inhibition of estradiol receptor/Src association and cell growth by an estradiol receptor alpha tyrosine-phosphorylated peptide. Mol Cancer Res 2007; 5: 1213-21.
18. Soderberg O, Gullberg M, Jarvius M, et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods 2006; 3: 995-1000.
19. Nath-Sain S, Marignani PA,. LKB1 catalytic activity contributes to estrogen receptor alpha signaling. Mol Biol Cell 2009; 20: 2785-95.
20. Dowling RJ, Zakikhani M, Fantus IG, et al. Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. Cancer Res 2007; 67: 10804-12.
21. Shaw RJ, Bardeesy N, Manning BD, et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 2004; 6: 91-9.
22. Vadlamudi RK, Manavathi B, Balasenthil S, et al. Functional implications of altered subcellular localization of PELP1 in breast cancer cells. Cancer Res 2005; 65: 7724-32.
23. Gallo D, Jacquot Y, Laurent G, et al. Calmodulin, a regulatory partner of the estrogen receptor alpha in breast cancer cells. Mol Cell Endocrinol 2008; 291: 20-6.
24. Wang C, Fan S, Li Z, et al. Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity. Cancer Res 2005; 65: 6557-67.
25. Dorfman J, Macara IG,. STRADalpha regulates LKB1 localization by blocking access to importin-alpha, and by association with Crm1 and exportin-7. Mol Biol Cell 2008; 19: 1614-26.
26. Sebbagh M, Santoni MJ, Hall B, et al. Regulation of LKB1/STRAD localization and function by E-cadherin. Curr Biol 2009; 19: 37-42.
27. Zhan YY, Chen Y, Zhang Q, et al. The orphan nuclear receptor Nur77 regulates LKB1 localization and activates AMPK. Nat Chem Biol 2012; 8: 897-904.
28. Taliaferro-Smith L, Nagalingam A, Zhong D, et al. LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells. Oncogene 2009; 28: 2621-33.
29. Zhuang ZG, Di GH, Shen ZZ, et al. Enhanced expression of LKB1 in breast cancer cells attenuates angiogenesis, invasion, and metastatic potential. Mol Cancer Res 2006; 4: 843-9.
30. McCarthy A, Lord CJ, Savage K, et al. Conditional deletion of the Lkb1 gene in the mouse mammary gland induces tumor formation. J Pathol 2009; 219: 306-16.
31. Shen Z, Wen XF, Lan F, et al. The tumor suppressor gene LKB1 is associated with prognosis in human breast carcinoma. Clin Cancer Res 2002; 8: 2085-90.
32. Bignell GR, Barfoot R, Seal S, et al. Low frequency of somatic mutations in the LKB1/Peutz-Jeghers syndrome gene in sporadic breast cancer. Cancer Res 1998; 58: 1384-6.
33. Forster LF, Defres S, Goudie DR, et al. An investigation of the Peutz-Jeghers gene (LKB1) in sporadic breast and colon cancers. J Clin Pathol 2000; 53: 791-3.
34. Jeon SM, Chandel NS, Hay N,. AMPK regulates NADPH homeostasis to promote tumor cell survival during energy stress. Nature 2012; 485: 661-5.
35. Zhong D, Liu X, Khuri FR, et al. LKB1 is necessary for Akt-mediated phosphorylation of proapoptotic proteins. Cancer Res 2008; 68: 7270-7.